Vis enkel innførsel

dc.contributor.authorSnipstad, Sofie
dc.contributor.authorVikedal, Krister
dc.contributor.authorMaardalen, Matilde
dc.contributor.authorKurbatskaya, Anna
dc.contributor.authorSulheim, Einar
dc.contributor.authorDavies, Catharina de Lange
dc.date.accessioned2021-10-05T07:59:26Z
dc.date.available2021-10-05T07:59:26Z
dc.date.created2021-09-27T14:40:20Z
dc.date.issued2021
dc.identifier.citationAdvanced Drug Delivery Reviews. 2021, 177, .en_US
dc.identifier.issn0169-409X
dc.identifier.urihttps://hdl.handle.net/11250/2787605
dc.description.abstractSuccessful delivery of drugs and nanomedicine to tumors requires a functional vascular network, extravasation across the capillary wall, penetration through the extracellular matrix, and cellular uptake. Nanomedicine has many merits, but penetration deep into the tumor interstitium remains a challenge. Failure of cancer treatment can be caused by insufficient delivery of the therapeutic agents. After intra-venous administration, nanomedicines are often found in off-target organs and the tumor extracellular matrix close to the capillary wall. With circulating microbubbles, ultrasound exposure focused toward the tumor shows great promise in improving the delivery of therapeutic agents. In this review, we address the impact of focused ultrasound and microbubbles to overcome barriers for drug delivery suchnas perfusion, extravasation, and transport through the extracellular matrix. Furthermore, we discuss the induction of an immune response with ultrasound and delivery of immuno-therapeutics. The review dis-cusses mainly preclinical results and ends with a summary of ongoing clinical trials.en_US
dc.language.isoengen_US
dc.publisherElsevier Scienceen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleUltrasound and microbubbles to beat barriers in tumors: Improving delivery of nanomedicineen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber14en_US
dc.source.volume177en_US
dc.source.journalAdvanced Drug Delivery Reviewsen_US
dc.identifier.doihttps://doi.org/10.1016/j.addr.2021.113847
dc.identifier.cristin1939170
dc.relation.projectNorges forskningsråd: 26228en_US
dc.relation.projectHelseforetak: 90270600en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal